Our testicular cancer nomogram is a tool designed to help predict the likelihood of finding active cancer or a type of tumor called teratoma in tissue removed during post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) following first-line chemotherapy for non-seminomatous germ cell tumors. pcRPLND is a surgery to remove lymph nodes from the back of the abdomen (the retroperitoneal area). This tool is only appropriate for patients who have undergone first-line chemotherapy for a type of testicular cancer called metastatic non-seminomatous germ cell tumors.
Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of testicular cancer procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
Use our Probability of Residual Teratoma and/or non-Teratomatous Germ Cell Tumor on Pathology After Post-Chemotherapy Retroperitoneal Lymph Node Removal nomogram.